Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Sørensen · SciRah

Researcher profile · Semantic Scholar

B. Sørensen

Share profile

B. Sørensen — researcher profile on SciRah

h-index: 38
Works: 194
Citations: 5,247

Most-cited papers

Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma
K. Jakobsen, Birgitte Sandfeld Paulsen, R. Bæk, K. Varming +2 more
2015Journal of Extracellular Vesicles316 citations Open access
Semantic Scholar
Exosomal Proteins as Diagnostic Biomarkers in Lung Cancer
Birgitte Sandfeld-Paulsen, K. Jakobsen, R. Bæk, B. Folkersen +5 more
2016Journal of Thoracic Oncology270 citations Open access
Semantic Scholar
Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays
B. Weber, P. Meldgaard, H. Hager, Lin Wu +5 more
2014BMC Cancer153 citations Open access
Semantic Scholar
Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib.
S. F. Sorensen, C. Demuth, B. Weber, B. Sørensen +1 more
2016Lung Cancer111 citations
Semantic Scholar
The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
K. Jakobsen, C. Demuth, B. Sørensen, A. Nielsen
2016Translational Lung Cancer Research103 citations Open access
Semantic Scholar
Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
C. Demuth, K. Spindler, J. Johansen, N. Pallisgaard +4 more
2018Translational Oncology72 citations Open access
Semantic Scholar
Day-to-day and within-day biological variation of cell-free DNA
A. T. Madsen, J. A. Højbjerg, B. Sørensen, A. Winther-Larsen
2019EBioMedicine65 citations Open access
Semantic Scholar
Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients
A. Winther-Larsen, C. Demuth, J. Fledelius, A. T. Madsen +3 more
2017British Journal of Cancer56 citations Open access
Semantic Scholar
Metabolic tumor burden as marker of outcome in advanced EGFR wild-type NSCLC patients treated with erlotinib.
A. Winther-Larsen, J. Fledelius, B. Sørensen, P. Meldgaard
2016Lung Cancer44 citations
Semantic Scholar
Clonal driver neoantigen loss under EGFR TKI and immune selection pressures
Maise Al Bakir, J. Reading, Samuel Gamble, R. Rosenthal +37 more
2025Nature43 citations Open access
Semantic Scholar
The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients
S. Bønløkke, M. Stougaard, B. Sørensen, B. Booth +9 more
2022Cells38 citations Open access
Semantic Scholar
Exosomes and Their Potential for Detection of Lung Cancer
Birgitte Sandfeld Paulsen, K. Jacobsen, R. Bæk, P. Meldgaard +3 more
201538 citations
Semantic Scholar
TERT promoter mutated circulating tumor DNA as a biomarker for prognosis in hepatocellular carcinoma
S. Oversoe, M. Clement, M. H. Pedersen, B. Weber +6 more
2020Scandinavian Journal of Gastroenterology36 citations
Semantic Scholar
Correlation between early dynamics in circulating tumour DNA and outcome from FOLFIRI treatment in metastatic colorectal cancer
Iben Lyskjær, C. Kronborg, M. Rasmussen, B. Sørensen +8 more
2019Scientific Reports34 citations Open access
Semantic Scholar
Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer.
E. B. F. Ebert, T. Mcculloch, K. Hansen, H. Linnet +2 more
2019Lung Cancer33 citations
Semantic Scholar
Increased PD-L1 expression in erlotinib-resistant NSCLC cells with MET gene amplification is reversed upon MET-TKI treatment
C. Demuth, M. Andersen, K. Jakobsen, A. T. Madsen +1 more
2017OncoTarget33 citations Open access
Semantic Scholar
Neurofilament Light Chain as A Biomarker for Brain Metastases
A. Winther-Larsen, C. V. B. Hviid, P. Meldgaard, B. Sørensen +1 more
2020Cancers32 citations Open access
Semantic Scholar
cGAS-STING pathway expression as a prognostic tool in NSCLC
Kristine Raaby Gammelgaard, Birgitte Sandfeld-Paulsen, S. H. Godsk, C. Demuth +3 more
2020Translational Lung Cancer Research30 citations Open access
Semantic Scholar
Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint Inhibitors
J. Pedersen, A. T. Madsen, K. R. Gammelgaard, N. Aggerholm-Pedersen +3 more
2020Cancers30 citations Open access
Semantic Scholar
IGF1R depletion facilitates MET-amplification as mechanism of acquired resistance to erlotinib in HCC827 NSCLC cells
Dianna Hussmann, A. T. Madsen, K. Jakobsen, Yong-Lun Luo +2 more
2017OncoTarget27 citations Open access
Semantic Scholar
Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients.
J. A. Højbjerg, E. B. F. Ebert, M. Clement, A. Winther-Larsen +2 more
2019Lung Cancer26 citations Open access
Semantic Scholar
Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells
M. Clement, K. R. Gammelgaard, A. Nielsen, B. Sørensen
2020Translational Lung Cancer Research24 citations Open access
Semantic Scholar
Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC
K. R. Gammelgaard, Johan Vad-Nielsen, M. Clement, Simone Weiss +5 more
2018Translational Oncology24 citations Open access
Semantic Scholar
Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma
J. Pedersen, M. Sokač, B. Sørensen, A. Luczak +4 more
2022Cancers23 citations Open access
Semantic Scholar
Cell-free DNA levels and correlation to stage and outcome following treatment of locally advanced rectal cancer
A. Boysen, Y. Wettergren, B. Sørensen, H. Taflin +2 more
2017Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine23 citations Open access
Semantic Scholar
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo
Signe Neldeborg, Johannes Frasez Soerensen, C. Møller, Marie Bill +10 more
2023Leukemia22 citations Open access
Semantic Scholar
Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients.
Eva Boysen Fynboe Ebert, T. Mcculloch, Karin Holmskov Hansen, H. Linnet +2 more
2020Lung Cancer22 citations
Semantic Scholar
Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer Patients
A. T. Madsen, A. Winther-Larsen, T. Mcculloch, P. Meldgaard +1 more
2020Cancers22 citations Open access
Semantic Scholar
The prognostic role of inflammation-scores on overall survival in lung cancer patients
Birgitte Sandfeld-Paulsen, P. Meldgaard, B. Sørensen, A. Safwat +1 more
2019Acta oncologica22 citations Open access
Semantic Scholar
Cell-free Chromatin Immunoprecipitation (cfChIP) from blood plasma can determine gene-expression in tumors from non-small-cell lung cancer patients.
Johan Vad-Nielsen, P. Meldgaard, B. Sørensen, A. Nielsen
2020Lung Cancer21 citations
Semantic Scholar
Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: a post-hoc subgroup analysis with pooled data from two phase II clinical trials
I. J. Eide, S. Stensgaard, Å. Helland, S. Ekman +7 more
2021Translational Lung Cancer Research20 citations Open access
Semantic Scholar
A method for treatment monitoring using circulating tumour DNA in cancer patients without targetable mutations
C. Demuth, A. Winther-Larsen, A. T. Madsen, P. Meldgaard +1 more
2018OncoTarget20 citations Open access
Semantic Scholar
Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma
S. Oversoe, M. Clement, B. Weber, H. Grønbæk +3 more
2020BMC Cancer19 citations Open access
Semantic Scholar
Intra‐individual variation of circulating tumour DNA in lung cancer patients
J. A. Højbjerg, A. T. Madsen, H. Schmidt, S. F. Sorensen +3 more
2019Molecular Oncology19 citations Open access
Semantic Scholar
Co‐expression of HER3 and MUC1 is associated with a favourable prognosis in patients with bladder cancer
Trine O. Nielsen, M. Borre, E. Nexo, B. Sørensen
2015BJU International19 citations
Semantic Scholar
Cell‐free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patients
Christoffer Trier Maansson, P. Meldgaard, M. Stougaard, A. Nielsen +1 more
2023Molecular Oncology18 citations Open access
Semantic Scholar
Genetic polymorphism in the epidermal growth factor receptor gene predicts outcome in advanced non-small cell lung cancer patients treated with erlotinib.
A. Winther-Larsen, P. Nissen, K. Jakobsen, C. Demuth +2 more
2015Lung Cancer18 citations
Semantic Scholar
The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment
C. Demuth, A. T. Madsen, B. Weber, Lin Wu +2 more
2018BMC Cancer17 citations Open access
Semantic Scholar
Regulatory dissection of the CBX5 and hnRNPA1 bi-directional promoter in human breast cancer cells reveals novel transcript variants differentially associated with HP1α down-regulation in metastatic cells
Johan Vad-Nielsen, K. Jakobsen, T. F. Daugaard, Rune Thomsen +3 more
2016BMC Cancer17 citations Open access
Semantic Scholar
HER4 and its cytoplasmic isoforms are associated with progression-free survival of malignant melanoma
Trine O. Nielsen, S. Poulsen, F. Journé, G. Ghanem +1 more
2014Melanoma research17 citations
Semantic Scholar
Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer
S. Stensgaard, A. Thomsen, Sofie Helstrup, P. Meldgaard +1 more
2023Translational Lung Cancer Research16 citations Open access
Semantic Scholar
Metabolism of 25-Hydroxy-Vitamin D in Human Macrophages Is Highly Dependent on Macrophage Polarization
R. Nygaard, M. Nielsen, Kristian W. Antonsen, C. Højskov +2 more
2022International Journal of Molecular Sciences16 citations Open access
Semantic Scholar
ctDNA-based minimal residual disease detection in lung cancer patients treated with curative intended chemoradiotherapy using a clinically transferable approach.
Lærke Rosenlund Nielsen, S. Stensgaard, P. Meldgaard, B. Sørensen
2024Cancer Treatment and Research Communications14 citations Open access
Semantic Scholar
Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells
Johan Vad-Nielsen, N. Staunstrup, Magnus Lindkvist Kjeldsen, Nina Dybdal +8 more
2023Translational Lung Cancer Research14 citations Open access
Semantic Scholar
Circulating cell‐free HPV DNA is a strong marker for disease severity in cervical cancer
S. Bønløkke, T. Steiniche, B. Sørensen, G. Nyvang +7 more
2023Molecular Oncology14 citations Open access
Semantic Scholar
Comparison of culture media reveals that non‐essential amino acids strongly affect the phenotype of human monocyte‐derived macrophages
Kristian W. Antonsen, H. N. Friis, B. Sørensen, A. Etzerodt +2 more
2023Immunology13 citations Open access
Semantic Scholar
Early Change in FDG-PET Signal and Plasma Cell-Free DNA Level Predicts Erlotinib Response in EGFR Wild-Type NSCLC Patients
A. Winther-Larsen, J. Fledelius, C. Demuth, C. Bylov +2 more
2016Translational Oncology13 citations Open access
Semantic Scholar
EGFR transcription in non‐small‐cell lung cancer tumours can be revealed in ctDNA by cell‐free chromatin immunoprecipitation (cfChIP)
Christoffer Trier Månsson, Johan Vad-Nielsen, P. Meldgaard, A. Nielsen +1 more
2021Molecular Oncology12 citations Open access
Semantic Scholar
Cell-Free DNA and Clinical Characteristics in Patients with Small Intestinal or Pancreatic Neuroendocrine Tumors
S. Oversoe, B. Sørensen, E. Tabaksblat, H. Grønbaek +1 more
2021Neuroendocrinology12 citations
Semantic Scholar
STAT3 is over-activated within CD163pos bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS
M. Andersen, N. F. Andersen, K. L. Lauridsen, A. Etzerodt +5 more
2021Cancer Immunology and Immunotherapy12 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Meldgaard×25
Invite
P. Meldgaard — researcher profile on SciRah
C. Demuth×11
Invite
C. Demuth — researcher profile on SciRah
A. T. Madsen×9
Invite
A. T. Madsen — researcher profile on SciRah
A. Winther-Larsen×9
Invite
A. Winther-Larsen — researcher profile on SciRah

×8

Invite

A. Nielsen — researcher profile on SciRah

Invite

K. Jakobsen — researcher profile on SciRah

Invite

B. Weber — researcher profile on SciRah

M. Stougaard×5

Invite

M. Stougaard — researcher profile on SciRah

Invite

M. Clement — researcher profile on SciRah

Johan Vad-Nielsen×5

Invite

Johan Vad-Nielsen — researcher profile on SciRah

Birgitte Sandfeld-Paulsen×4

Invite

Birgitte Sandfeld-Paulsen — researcher profile on SciRah

Invite

R. Bæk — researcher profile on SciRah